Dr Agarwal's Health Care AGARWALEYE
India's largest eye-care chain (Dr Agarwal's Eye Hospitals) with centres across India and in Africa; listed Feb 2025
Mapped in 1 theme: Hospitals & Healthcare.
Where Dr Agarwal's Health Care sits in the supply chain
Dr Agarwal's Health Care appears in 1 supply-chain layer in one theme, Hospitals & Healthcare.
Hospitals & Healthcare › Single-specialty chains
OperatorOther companies in this layer
Revenue and profit
| ₹ Cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 696 | 1,018 | 1,332 | 1,711 | 2,080 |
| Net profit | 43 | 103 | 95 | 110 | 168 |
Latest-year revenue ₹2,080 Cr (FY26, company-wide).
Strengths
- Scale in a fragmented specialty - cataract, refractive and retina surgery in a repeatable format
- Backed by TPG and Temasek; acquisitive in regional eye chains
- Premium lenses and refractive surgery lift revenue per patient
Risks
- Much of eye care is paid in cash - sensitive to price competition
- Acquisition-heavy growth adds goodwill
- Not to be confused with its listed subsidiary Dr Agarwal's Eye Hospital Ltd (BSE)
Common questions
What does Dr Agarwal's Health Care do?
India's largest eye-care chain (Dr Agarwal's Eye Hospitals) with centres across India and in Africa; listed Feb 2025.
Where does Dr Agarwal's Health Care sit in the supply chain?
Dr Agarwal's Health Care (NSE: AGARWALEYE) is mapped in 1 supply-chain layer: Single-specialty chains (Hospitals & Healthcare).
Who are Dr Agarwal's Health Care's peers?
In the Single-specialty chains layer of Hospitals & Healthcare: Rainbow Children's Medicare, HealthCare Global Enterprises (HCG), Shalby, Indira IVF (not NSE-listed) and Cloudnine Hospitals (not NSE-listed).
What is Dr Agarwal's Health Care's market cap and valuation?
As of 6 Nov 2026: market cap ₹16,379 Cr, P/E 91.4x, ROCE 10.9%, ROE 6.0%, dividend yield 0%.